Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment
Advanced Science · 2026
DOI: 10.1002/advs.202519213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, 2026. Verfasst von Wanrong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui Medical University, Hefei, P. R. China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nanomedicine, Biomimetics, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 291 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants for Scientific Research of BSKY from Anhui Medical University, Scientific Research Level Improvement Plan of Anhui Medical University, Scientific Research Foundation of the Educational Department of Anhui Province.
Abstract (Originalsprache)
Biomimetics is an interdisciplinary field that involves studying the structures, functions, principles, and behaviors of biological systems to draw inspiration and apply this knowledge to technological innovation and engineering design, thereby addressing complex challenges. Biomimetic nanomedicine represents a specific application of biomimetics within the realm of nanomedicine, where biological components are mimicked to construct sophisticated nanodrug delivery systems. These biomimetic nanosystems exhibit multiple unique advantages, including targeted delivery to cells within the tumor microenvironment (TME), prolonged in vivo circulation time, enhanced antigen/adjuvant loading capacity, and high biocompatibility. These properties collectively enhance the efficacy of chemotherapy, radiotherapy, immunotherapy, and photodynamic therapy (PDT) by improving tumor‐specific targeting and reducing off‐target toxicity, thereby establishing biomimetic nanomedicines as a promising platform for reprogramming the TME. This review highlights the categorization, design principles, and manufacturing strategies of biomimetic nanodrugs, providing a systematic review of the interplay between the TME and biomimetic nanomedicines, and elucidating how their interaction potentiates tumor‐killing efficacy. Despite encouraging progress in biomimetic nanomedicines, challenges remain in their clinical translation, including biosafety concerns, scalable manufacturing processes, and optimal drug delivery efficiency. Advances in nanotechnology and precision engineering offer promising avenues for developing personalized biomimetic nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Anhui Medical University, Hefei, P. R. China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, P. R. China.
- Department of Endocrinology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China.
- Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui Public Health Clinical Center, Hefei, Anhui, P. R. China.
ORCID-Profile: Xiaoyan He
Förderung
- Grants for Scientific Research of BSKY from Anhui Medical University
- Scientific Research Level Improvement Plan of Anhui Medical University
- Scientific Research Foundation of the Educational Department of Anhui Province
- Special Fund for Scientific Research of Wu Jieping Medical Foundation
Zitieren
APA
Wang, W., Mu, S., Zhang, J., Shan, G., Li, X., Wang, R., Guo, T., & He, X. (2026). Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment. Advanced Science. https://doi.org/10.1002/advs.202519213
Vancouver
Wang W, Mu S, Zhang J, Shan G, Li X, Wang R, et al. Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment. Advanced Science. 2026. doi:10.1002/advs.202519213
BibTeX
@article{Wang2026,
author = {Wang, Wanrong and Mu, Siqi and Zhang, Juan and Shan, Guisong and Li, Xueqian and Wang, Ran and Guo, Tao and He, Xiaoyan},
title = {Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202519213}
}
EUVIMED